The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML

A Redaelli, JM Stephens, BL Laskin… - Expert review of …, 2003 - Taylor & Francis
Given the recent advances in the treatment of hematologic malignancies and the many other
treatments on the horizon, physicians and payers will be faced with the critical decisions of …
被引用次数：57 相关文章

The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.

A Redaelli, JM Stephens, BL Laskin… - Expert Review of …, 2003 - europepmc.org
Given the recent advances in the treatment of hematologic malignancies and the many other
treatments on the horizon, physicians and payers will be faced with the critical decisions of …

The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML

A Redaelli, JM Stephens, BL Laskin… - Expert Review of …, 2003 - go.gale.com
Given the recent advances in the treatment of hematologic malignancies and the many other
treatments on the horizon, physicians and payers will be faced with the critical decisions of …

The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML

A Redaelli, JM Stephens, BL Laskin… - Expert Review of …, 2003 - search.proquest.com
Given the recent advances in the treatment of hematologic malignancies and the many other
treatments on the horizon, physicians and payers will be faced with the critical decisions of …

The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML

A Redaelli, JM Stephens, BL Laskin… - Expert review of …, 2003 - pubmed.ncbi.nlm.nih.gov
Given the recent advances in the treatment of hematologic malignancies and the many other
treatments on the horizon, physicians and payers will be faced with the critical decisions of …